The Board of Regents of the University of Texas System design mark 8023907
"Design mark 8023907" is a figurative mark owned by The Board of Regents of the University of Texas System, filed at the USPTO on March 25, 2022. It is registered and covers classes 35, 36, 41, 42 and 44.
- Status
- Registered
- Since November 11, 2025
- Filed
- March 25, 2022
- Registered
- November 11, 2025
- Expires
- Not recorded
- Application no.
- 97331599
- Registration no.
- 8023907
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 5 classes
Who owns The Board of Regents of the University of Texas System design mark 8023907
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
The Board of Regents of the University of Texas System
Austin, United States
Representative
Robin Lightner Maisashvili
Fibbe Lightner LLP
What the mark covers
The products and services The Board of Regents of the University of Texas System design mark 8023907 is filed for, grouped by Nice class.
Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease
Charitable fundraising services
Educational services, namely, conducting programs, seminars and lectures in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer and diseases
Medical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the fields of immunobiology, immunotherapy, antibodies, and oncology research, development, testing, analysis and data; medical research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; pharmaceutical research services; pharmaceutical research services relating to cancer
Medical services; Medical services relating to cancer; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information on cancer treatment; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Notice of acceptance of statement of use e-mailed
- Allowed principal register - sou accepted
- Statement of use processing complete
- Case assigned to intent to use paralegal
- Use amendment filed
- Teas statement of use received
- Notice of approval of extension request e-mailed
- Sou extension 2 granted
10 earlier steps on the official record.
About The Board of Regents of the University of Texas System design mark 8023907
Who owns the trademark "Design mark 8023907"?
The USPTO trademark "Design mark 8023907" (application 97331599) is owned by The Board of Regents of the University of Texas System.
What is the status of "Design mark 8023907"?
Its status at the USPTO is: registered.
When was "Design mark 8023907" registered?
It was registered on November 11, 2025.
Get this data via the API
Everything on this page comes from the Signa API. Pull The Board of Regents of the University of Texas System design mark 8023907 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a5b-ca5f-7405-9216-161a2e1e3d63
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a5b-ca5f-7405-9216-161a2e1e3d63",
"object": "trademark",
"mark_text": "[Design Mark]",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "97331599",
"filing_date": "2022-03-25",
"nice_classes": [
35,
36,
41,
42,
44
],
"owners": [
{
"name": "The Board of Regents of the University of Texas System",
"entity_id": "ent_019ebba6-35df-773f-ba53-29ec681e130f"
}
]
}